Manulife (Manufacturers Life Insurance)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $291M | Sell |
|
|||||
2025
Q1 | $305M | Sell |
|
|||||
2024
Q4 | $583M | Sell |
|
|||||
2024
Q3 | $532M | Sell |
|
|||||
2024
Q2 | $453M | Sell |
|
|||||
2024
Q1 | $522M | Sell |
|
|||||
2023
Q4 | $618M | Buy |
|
|||||
2023
Q3 | $320M | Buy |
|
|||||
2023
Q2 | $323M | Buy |
|
|||||
2023
Q1 | $343M | Buy |
|
|||||
2022
Q4 | $352M | Buy |
|
|||||
2022
Q3 | $195M | Buy |
|
|||||
2022
Q2 | $195M | Buy |
|
|||||
2022
Q1 | $187M | Buy |
|
|||||
2021
Q4 | $227K | Sell |
|
|||||
2021
Q3 | $271M | Sell |
|
|||||
2021
Q2 | $268M | Buy |
|
|||||
2021
Q1 | $249M | Sell |
|
|||||
2020
Q4 | $239M | Buy |
|
|||||
2020
Q3 | $257M | Buy |
|
|||||
2020
Q2 | $289M | Sell |
|
|||||
2020
Q1 | $332M | Buy |
|
|||||
2019
Q4 | $226M | Sell |
|
|||||
2019
Q3 | $225M | Sell |
|
|||||
2019
Q2 | $246M | Sell |
|
|||||
2019
Q1 | $281M | Buy |
|
|||||
2018
Q4 | $268M | Sell |
|
|||||
2018
Q3 | $347M | Sell |
|
|||||
2018
Q2 | $342M | Sell |
|
|||||
2018
Q1 | $381M | Sell |
|
|||||
2017
Q4 | $386M | Sell |
|
|||||
2017
Q3 | $441M | Sell |
|
|||||
2017
Q2 | $438M | Buy |
|
|||||
2017
Q1 | $280M | Buy |
|
|||||
2016
Q4 | $240M | Sell |
|
|||||
2016
Q3 | $272M | Buy |
|
|||||
2016
Q2 | $210M | Buy |
|
|||||
2016
Q1 | $209M | Sell |
|
|||||
2015
Q4 | $299K | Buy |
|
|||||
2015
Q3 | $276K | Buy |
|
|||||
2015
Q2 | $318K | Buy |
|
|||||
2015
Q1 | $249K | Buy |
|
|||||
2014
Q4 | $235K | Buy |
|
|||||
2014
Q3 | $207K | Buy |
|
|||||
2014
Q2 | $137M | Sell |
|
|||||
2014
Q1 | $147K | Buy |
|
|||||
2013
Q4 | $149K | Sell |
|
|||||
2013
Q3 | $134K | Buy |
|
|||||
2013
Q2 | $108M | Buy |
|